Singapore continues to shine as the country to be in as ASEAN grows

Adding to existing manufacturing capabilities in Singapore, Novartis has pledged another $500 million to establish a biomanufacturing facility in the country. This is the most recent in a line of such activities and adds to the existing pharmaceutical and biologics production expertise belonging to ...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

EU Commission proposes €10 billion in funding for 10 public-private partnerships to bolster the region's innovation ecosystem

News Commentary | March 04, 2021

The €10 billion will be split across 10 major projects, including healthcare, circular economy, hydrogen, and connectivity technologies. At its core, this is a significant step by the EU to strengthen its leading position in certain areas while also keeping pace with rising competition from around ... Not part of subscription

Dubai's economic agency launches new digital health-focused incubator and accelerator

News Commentary | April 30, 2021

The new incubator and accelerator, called Ztartup, aims to further the role of Dubai as a knowledge center and innovation hub in the region. The Middle East, most notably Saudi Arabia, the United Arab Emirates, and Qatar, has overseen major investments from the government in building R&D ... Not part of subscription

BioNTech to set up its regional headquarters and an mRNA vaccine manufacturing facility in Singapore

News Commentary | May 12, 2021

Pfizer's biotech partner that developed the mRNA vaccine against COVID‑19 has moved quickly to ensure it can be elastic in its response to shifting regional and global supply needs for its vaccine given the unpredictable outbreaks in recent times. This move also comes just weeks after Sanofi ... To read more, click here.